Who is sponsoring NCT05365204?

NCT05365204 is sponsored by National Taiwan University Hospital Hsin-Chu Branch.

What drugs are being tested in NCT05365204?

Interventions in NCT05365204: Near infrared fluorescence navigated sentinel lymph node mapping.

What condition does NCT05365204 study?

NCT05365204 studies Breast Cancer, Sentinel Lymph Node.

Is NCT05365204 still recruiting?

NCT05365204 is currently status unknown. Last updated 9 May 2022.

Last reviewed 2022-05-09 · How we verify

NCT05365204

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study for Optimization of 6% Hydroxyethyl Starch Based Indocyanine Green Near-infrared Fluorescence Navigated Sentinel Lymph Node Biopsy for Breast Cancer Patients

Status unknown Phase 1 Last updated 9 May 2022

What this trial tests

Phase 1 trial testing Near infrared fluorescence navigated sentinel lymph node mapping in Breast Cancer in 24 participants. Status unknown.

Timeline

8 April 2022

Primary endpoint
7 April 2023

7 April 2023

Quick facts

Lead sponsor	National Taiwan University Hospital Hsin-Chu Branch
Phase	Phase 1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	24
Start date	8 April 2022
Primary completion	7 April 2023
Estimated completion	7 April 2023
Sites	1 location across Taiwan

Drugs / interventions tested

Near infrared fluorescence navigated sentinel lymph node mapping

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Sentinel Lymph Node — all drugs for Sentinel Lymph Node →

Sponsor

National Taiwan University Hospital Hsin-Chu Branch

Who can join

20 and older, any sex, with Breast Cancer or Sentinel Lymph Node. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study for dosage-image optimization of 6% hydroxyethyl starch diluted indocyanine green for near-infrared fluorescence navigated sentinel lymph node mapping for breast cancer patient.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Novel Injection Protocol Using Voluven®-Assisted Indocyanine Green with Improved Near-Infrared Fluorescence Guidance in Breast Cancer Sentinel Lymph Node Mapping-A Translational Study.
Hsieh YC, Guo KW, Wang MW, Su SP, et al · · 2023 · cited 4× · PMID 37605084 · DOI 10.1245/s10434-023-14129-4
A Dose-Image Optimization Trial for Voluven®-Assisted Indocyanine Green Fluorescence-Guided Breast Cancer Sentinel Lymph Node Surgery.
Hsieh YC, Huang CS, Chan YH. · · 2025 · PMID 40549082 · DOI 10.1245/s10434-025-17696-w

Verify or expand the search:

Other trials of Near infrared fluorescence navigated sentinel lymph node mapping

Trials testing the same drug.

NCT05365191 — A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients · NA · unknown

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other National Taiwan University Hospital Hsin-Chu Branch trials

Trials by the same sponsor.

NCT06426251 — Photobiomodulation Therapy in Patients Receiving Total Knee Arthroplasty · NA · recruiting
NCT05879575 — Effects and Pathophysiology of Weight Training on Pregnancy-related Pelvic Girdle Pain (PPGP) · NA · unknown
NCT07012200 — Effect of Immersive Interactive Nursing Guidance on Anxiety, Cognition, and Self-efficacy in CHD Patients Undergoing Car · NA · terminated
NCT06103045 — The Effects of Unilateral and Bilateral Mirror Therapy on Upper Extremity Function of Stroke at Acute Stage. · NA · completed
NCT05764278 — The Efficacy and Safety of Early Rehabilitation in Large Vessel Occlusion Patients After Intra-arterial Thrombectomy: A · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05365204 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital Hsin-Chu Branch
Last refreshed: 9 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05365204.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing